In a similar study, when apigenin was used in combination with the BCL2 inhibitor navitoclax for 48 h, there was an upregulation of BAX and BIM gene expression and protein levels, which led to apoptotic cell death in colon cancer (HTC-116) cells60. Here, BAX is linked to colonic neoplasm.